Statistics and logistics: Design of Ebola vaccine trials in West Africa

Abstract

Get full access to this article

View all access options for this article.

References

Agnandji

Huttner

Zinser

. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe—preliminary report. N Engl J Med. Epub ahead of print 1 April 2015. DOI: 10.1056/NEJMoa1502924.

Ledgerwood

DeZure

Stanley

. Chimpanzee adenovirus vector Ebola vaccine—preliminary report. N Engl J Med. Epub ahead of print 26 November 2014. DOI: 10.1056/NEJMoa1410863.

World Health Organization. Ebola vaccines, therapies, and diagnostics, http://www.who.int/medicines/emp_ebola_q_as/en/ (2015, accessed 5 November).

Huttner

Dayer

Yerly

. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infect Dis 2015; 15: 1156–1166.

Bellan

Pulliam

Pearson

. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect Dis 2015; 15: 703–10.

Brown

Lilford

RJ.

The stepped wedge trial design: a systematic review. BMC Med Res Methodol 2006; 6: 54.

Kennedy

Neaton

Lane

. Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: design, procedures & challenges. Clin Trials 2016; 13: 49–56.

World Health Organization. The Ebola outbreak in Liberia is over, http://www.who.int/mediacentre/news/statements/2015/liberia-ends-ebola/en/ (2015, accessed 5 November)

Piszczek

Partlow

Stepped-wedge trial design to evaluate Ebola treatments. Lancet Infect Dis 2015; 15: 762–763.

10.

Ebola ca Suffit Ring Vaccination Trial Consortium. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ 2015; 351: h3740.

11.

Henao-Restrepo

Longini

Egger

. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386: 857–866.